Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients
Open Access
- 1 April 2024
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 24 (1) , 1-8
Abstract
Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall prognosis of AIH is unknown, and treatment has not been established. To investigate the risk factors and prognosis of HCC in patients with AIH and identify appropriate management strategies. We studied patients with AIH including background liver disease, sex, age, complications, treatment, response to treatment, liver fibrosis, prognosis, and treatment. In 131 patients, deaths due to liver failure were more common early after the onset of AIH; however, deaths due to HCC increased gradually. HCC was observed in 12 patients (median age, 70 years; male/female, 4/8; cirrhosis at onset, 11; median time to carcinogenesis, 7 years). Cirrhosis at diagnosis was identified as a risk factor for carcinogenesis in the multivariate analysis (odds ratio, 41.36; p < 0.0001) and cumulative cancer rates were high. Multidisciplinary therapy other than immune checkpoint inhibitors was administered as treatment for HCC. Two of the three patients who used molecular-targeted drugs discontinued the treatment because of adverse events. HCC is an important cause of death in patients with AIH. Currently available drug therapies are limited and early detection is desirable. This trial was retrospectively registered in the Ethics Committee of Kagawa University School of Medicine under the identifier 2019 − 238, registered on 4 Feb 2020.Keywords
This publication has 28 references indexed in Scilit:
- Incidence and predictors of hepatocellular carcinoma in autoimmune hepatitis: A multicenter international studyDigestive and Liver Disease, 2023
- Global and regional long‐term survival following resection for HCC in the recent decade: A meta‐analysis of 110 studiesHepatology Communications, 2022
- Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver DiseasesHepatology, 2019
- Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessmentCancer Medicine, 2019
- Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in JapanJournal of Gastroenterology, 2012
- Long-term outcome of Japanese patients with type 1 autoimmune hepatitisHepatology, 2012
- Paris Criteria Are Effective in Diagnosis of Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap SyndromeClinical Gastroenterology and Hepatology, 2010
- Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients #Hepatology, 2009
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitisHepatology, 1988